AstraZeneca has warned it could relocate its vaccine manufacturing site on Merseyside to Philadelphia amid a deadlock in negotiations with the Labour government over plans to cut state aid promised to the project.
阿斯利康(AstraZeneca)警告稱,該公司可能將其位于默西塞德郡(Merseyside)的疫苗生產基地遷至費城。目前,該公司與工黨政府就削減對該項目承諾的國家援助計劃的談判陷入僵局。
您已閱讀7%(307字),剩余93%(4364字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。